Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  BioCryst Pharmaceuticals, Inc.    BCRX   US09058V1035

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

BioCryst Pharmaceuticals, Inc. : Commentary & Reports For: (NASDAQ: BCRX), (NYSE: GST)

04/24/2013 | 01:45pm US/Eastern
Recommend:
0

New York (April 24th, 2013) - BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) traded in the range of $1.75 and $1.97 during its latest trading session. The stock recorded the volume of 1.986 million shares. Currently, it is at $1.93, up 7.23 from its previous close. Its average daily trading volume stands at 1.085 million shares. Its MACD chart shows bullish trend and the stock is trading above its long term moving average price of $1.92. The company?s current market capitalization stands at $98.29 million.

BioCryst Pharmaceuticals stock is up 37.86 percent in the year 2013 so far while it lost 51.51 percent of its value in the past 52 weeks.

Find out if BCRX could maintain the momentum by getting the complete trend analysis report here:

http://www.monstertradingalerts.com/market-scan/?symbol=BCRX


Gastor Exploration Ltd. (NYSE: GST) stock is at $2.74, up 7.45 percent from its previous close of $2.55. The stock is up after the news of the company?s decision to sell its East Texas assets. Gastor Exploration shows bullish trend as it made the upward move with trading volume of 351,132 shares, in contrast to the average daily trading volume of 712,310 shares. Its bullish trend is further confirmed by its MACD chart and the stock is also trading above its 20 days SMA of $2.72.

Gastor Exploration stock is highly volatile with its beta at 1.57. The company?s market capitalization is at $186.18 million.

Get more news and reports on how to successfully trade GST here:

http://www.monstertradingalerts.com/market-scan/?symbol=GST

ABOUT US:

MonsterTradingAlerts.com issues momentum alerts on stocks that can provide gains to day traders. MonsterTradingAlerts.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. MonsterTradingAlerts.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals MonsterTradingAlerts.com is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading Penny Stocks. Gain an Edge by joining the MonsterTradingAlerts.com newsletter and receiving alerts from a Pro-Active team of researchers. Trading Alerts believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.MonsterTradingAlerts.com

Disclosure: MonsterTradingAlerts.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit MonsterTradingAlerts.com website, for complete risks and disclosures.

Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.

For full disclaimer visit; http://www.monstertradingalerts.com/disclaimer/

Contact Info:
Alexander K. Neumann
Monster Trading Alerts
info@MonsterTradingAlerts.com
347-905-5009


© Accesswire 2013
Recommend :
0
React to this article
Latest news on BIOCRYST PHARMACEUTICALS,
1d ago BIOCRYST PHARMACEUTICALS : Entry into a Material Definitive Agreement, Other Eve..
1d ago BioCryst Receives Additional NIAID Funding to Conduct a Non-Human Primate Stu..
08/16 BIOCRYST PHARMACEUTICALS : Leading Small-Cap Stars Health Care Stock for August ..
08/13 BIOCRYST PHARMACEUTICALS : Entry into a Material Definitive Agreement, Other Eve..
08/13 BioCryst Receives Additional NIAID Funding to Advance Development of BCX4430 ..
08/05 BIOCRYST PHARMACEUTICALS : BCRX) Continues to Rise on Potential Ebola Treatment
08/05 BIOCRYST PHARMACEUTICALS : Results of Operations and Financial Condition, Regula..
08/05 BioCryst Reports Second Quarter 2014 Financial Results
08/05 Leading Small-Cap Stars Health Care Stock for August 4 Morning Session is ERB..
07/23 BIOCRYST PHARMACEUTICALS : Patent Issued for Antiviral Treatments
Advertisement
Chart
Duration : Period :
BioCryst Pharmaceuticals,  Technical Analysis Chart | BCRX | US09058V1035 | 4-Traders
Income Statement Evolution
BioCryst Pharmaceuticals,  : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF